CD68 and Stroke: To determine which cell type is the likely source of increased TGF-β1 production after stroke, brain sections were stained with an anti-TGF-β1 antibody, colocalized with markers for astrocytes (GFAP), neurons (Milli-mark Pan-Neuronal marker), and monocytic immune cells (CD68).